Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2016

Segment Reporting

Schedule of financial information by reporting segment

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2016		2015		2016		2015
	(in thousands)
Net revenues:
Finished pharmaceutical products	$	63,756	$	50,075	$	122,310	$	100,947
API		4,277		3,778		5,089		9,792
Total net revenues		68,033		53,853		127,399		110,739
Gross profit:
Finished pharmaceutical products		30,598		12,634		56,422		25,487
API		1,116		684		194		1,111
Total gross profit		31,714		13,318		56,616		26,598
Operating expenses		21,384		23,578		42,211		44,119
Income (loss) from operations		10,330		(10,260)		14,405		(17,521)
Non-operating income (expenses)		(578)		31		(837)		1,095
Income (loss) before income taxes	$	9,752	$	(10,229)	$	13,568	$	(16,426)

Schedule of net revenues and long-lived assets by geographic region

	Net Revenue								Long-Lived Assets
	Three Months Ended				Six Months Ended
	June 30,				June 30,				June 30,		December 31,
	2016		2015		2016		2015		2016		2015
	(in thousands)
U.S.	$	67,550	$	52,757	$	126,089	$	105,717	$	101,430	$	100,404
China		—		—		—		—		33,835		28,547
France		483		1,096		1,310		5,022		13,382		13,210
Total	$	68,033	$	53,853	$	127,399	$	110,739	$	148,647	$	142,161